Investor Announcements - 2012
| ||
EKF announces 2012 Interim Results. | ||
| ||
EKF Diagnostics announces that subsidiaries of EKF have entered into a Settlement Agreement with HemoCue AB and HemoCue Inc in relation to patent-related litigation in Germany and the US. | ||
| ||
EKF Diagnostics announces that it has signed an exclusive license agreement with the Joslin Diabetes Center (“Joslin”). | ||
| ||
EKF Diagnostics announces that it has sold its Swiss subsidiary, International Brand Licensing AG for a cash consideration of £50,000, payable over a two year period. | ||
| ||
EKF Diagnostics announces its audited final results for the year ended 31 December 2011, a year of continued progress. | ||
Newsletter
Keep up to date with all our activities, events, exhibitions, promotions, investor news & more.